Repligen traded at $156.31 this Friday May 20th, increasing $1.68 or 1.08 percent since the previous trading session. Looking back, over the last four weeks, Repligen gained 0.07 percent. Over the last 12 months, its price fell by 13.84 percent. Looking ahead, we forecast Repligen to be priced at 147.09 by the end of this quarter and at 136.79 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
156.31
Daily Change
1.08%
Yearly
-13.84%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 125.14 2.74 2.24% -5.41%
Align Technology 275.15 1.26 0.46% -53.50%
BioMarin Pharmaceutical 80.58 1.30 1.64% 1.85%
Bristol-Myers Squibb 76.20 0.24 0.32% 13.65%
Bruker 60.53 -0.09 -0.14% -12.33%
Charles River Laboratories 233.23 1.46 0.63% -28.61%
Catalent 100.04 0.31 0.31% -1.75%
Danaher 252.08 2.77 1.11% -0.20%
Exact Sciences 54.22 0.22 0.41% -48.72%
Standard Biotools Inc 2.07 0.02 0.98% -63.04%
General Electric 75.28 -0.46 -0.61% -28.87%
Genesis Healthcare 0.10 0 0% -58.14%
Henry Schein 83.34 0.47 0.56% 6.42%
Illumina 243.58 2.83 1.18% -38.89%
IQVIA Holdings Inc 203.79 2.05 1.02% -13.92%
Mettler Toledo International 1,237.31 17.60 1.44% -3.05%
Myriad Genetics 21.69 0.15 0.70% -20.69%
NanoString Technologies 15.91 -0.03 -0.19% -68.17%
OraSure Technologies 5.53 0.08 1.47% -43.22%
Pacific Biosciences Of California 5.69 0.09 1.61% -78.05%
Patterson Companies 31.29 0.69 2.24% -9.87%
Pfizer 52.49 1.84 3.63% 31.39%
PerkinElmer 146.70 3.15 2.19% 1.33%
Peregrine Pharmaceuticals 12.68 0.19 1.52% -36.92%
Repligen 156.31 1.68 1.08% -13.84%
Bio Techne 368.82 2.38 0.65% -9.80%
Thermo Fisher Scientific 554.75 4.01 0.73% 19.99%
Waters 318.90 -4.93 -1.52% 2.14%
West Pharmaceutical Services 300.55 -1.66 -0.55% -9.87%
Dentsply International 37.74 0.42 1.12% -44.07%

Indexes Price Day Year
USND 11355 -33.88 -0.30% -15.71%
US2000 1773 -2.96 -0.17% -19.95%
US400 2385 -6.53 -0.27% -11.34%

Repligen
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.